Strep A, which can lead to serious illness and death if untreated, should be recognised as a Neglected Tropical Disease according to a leading infectious disease expert. Professor Michael Good AO, Principal Research Leader at Griffith University’s Institute for Glycomics, authored a paper published this week in PLOS Neglected Tropical Diseases. Neglected tropical diseases (NTDs) […]
Philanthropy has helped accelerate research into streptococcus leading scientists to exciting new discoveries in stroke and toxic shock prevention and treatments.
When Professor Michael Good first arrived at Griffith University seven years ago he never imagined that a vaccine to protect against the nasty Streptococcus A infection would already be at pharmaceutical development stage. But with the support of Vice Chancellor Ian O’Connor, Institute for Glycomics Director Professor Mark von Itzstein and a remarkable research team […]
Griffith University has developed the first needle-free vaccine for Strep A with the potential to help millions from suffering, uncovered the history of Aboriginal Australians in a world first genomic study and celebrated a scientist being named 2017 Queensland Australian of the Year – all in one short year.
The Institute for Glycomics has been delivering major translational outcomes from its research in recent months, which will be celebrated during Glycomics Week. Glycomics Week highlights the Institute’s growing significant research successes. The Institute recently announced partnerships with Chinese pharmaceutical, Olymvax Biopharmaceuticals Inc., for a new Strep A vaccine that has the enormous potential to help millions, […]
Griffith University’s Institute for Glycomics has developed a groundbreaking, combination vaccine that may finally beat Streptococcus A infections. Human trials are set to begin as early as next year.